IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• CD14 is a glycosylphosphatidylinositol (GPI)-linked protein on monocytes and neutrophils, crucial for lipopolysaccharide (LPS) recognition and monocyte-lymphocyte interactions.
• Interleukin-4 (IL-4) previously demonstrated to down-regulate CD14 expression transcriptionally.
• IL-13, a related cytokine, warrants investigation for its potential role in regulating CD14 expression.

Purpose of the Study:

• To investigate the effect of Interleukin-13 (IL-13) on CD14 expression in human monocytes.
• To determine the mechanism by which IL-13 affects CD14 expression.
• To assess the functional consequences of IL-13-mediated CD14 down-regulation on monocyte responses.

Main Methods:

• Human monocytes were treated with varying doses of IL-13.
• CD14, CD23, and CD11b expression levels were measured.
• CD14 transcript levels were quantified using RT-PCR.
• Monocyte responses, including TNF-alpha release, were assessed following LPS or PMA stimulation.

Main Results:

• IL-13 dose-dependently inhibited CD14 expression on human monocytes.
• IL-13 significantly reduced CD14 mRNA levels, indicating transcriptional regulation.
• IL-13 enhanced CD23 and CD11b expression.
• IL-13 pre-treatment inhibited CD14-mediated LPS-induced TNF-alpha release but also directly suppressed PMA-induced TNF-alpha release.
• No evidence of CD14 shedding or increased GPI anchor-cleaving enzyme activity was observed.

Conclusions:

• IL-13 down-regulates membrane CD14 expression primarily by suppressing CD14 gene transcription.
• The observed down-regulation of CD14 by IL-13 contributes to the inhibition of LPS-stimulated monocyte responses.
• IL-13 exhibits anti-inflammatory effects on LPS-stimulated monocytes through CD14 down-regulation and direct inhibition of cytokine secretion.